Aaron T Whiteley

Title: The Innovative Contributions of Aaron T. Whiteley

Introduction

Aaron T. Whiteley is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of nucleotide-based second messengers. With a total of 2 patents, his work has implications for various applications in molecular biology and medicine.

Latest Patents

Whiteley's latest patents include "CGAS/DNCV-like nucleotidyltransferases and uses thereof." This invention is based on the discovery and characterization of the CD-NTase family of proteins. It encompasses compositions comprising CD-NTases, methods of producing nucleotide-based second messengers using these polypeptides, and methods for screening modulators of their structure, expression, and activity. Another significant patent is "Human CGAS-DNA complex and encoded protein." This invention focuses on the human-specific regulatory control of cGAS and the structure of the active human cGAS-DNA complex. It also includes compositions comprising the modified hcGAS polypeptide, hcGAS-DNA complex, hcGAS-DNA-ATP complex, and methods for screening modulators of their structure, expression, and activity.

Career Highlights

Throughout his career, Whiteley has worked with prestigious institutions such as Harvard College and Dana-Farber Cancer Institute Inc. His research has contributed to advancements in understanding nucleotide signaling pathways and their potential therapeutic applications.

Collaborations

Whiteley has collaborated with esteemed colleagues, including Philip J. Kranzusch and John J. Mekalanos. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

Aaron T. Whiteley is a prominent inventor whose work in biotechnology has led to significant advancements in the understanding of nucleotide-based signaling. His patents reflect a commitment to innovation and a drive to explore the complexities of molecular biology.